<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">J. Infect. Dis</journal-id><journal-id journal-id-type="publisher-id">jid</journal-id><journal-title-group><journal-title>The Journal of Infectious Diseases</journal-title></journal-title-group><issn pub-type="ppub">0022-1899</issn><issn pub-type="epub">1537-6613</issn><publisher><publisher-name>Oxford University Press</publisher-name><publisher-loc>US</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6834069</article-id><article-id pub-id-type="doi">10.1093/infdis/jiz396</article-id><article-id pub-id-type="publisher-id">jiz396</article-id><article-categories><subj-group subj-group-type="heading"><subject>Major Articles and Brief Reports</subject><subj-group subj-group-type="category-toc-heading"><subject>Viruses</subject></subj-group></subj-group></article-categories><title-group><article-title>Impact of Zika Virus Emergence in French Guiana: A Large General Population Seroprevalence Survey</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-8064-445X</contrib-id><name><surname>Flamand</surname><given-names>Claude</given-names></name><xref ref-type="aff" rid="AF0001">1</xref><xref ref-type="corresp" rid="c1"/><!--<email>cflamand@pasteur-cayenne.fr</email>--></contrib><contrib contrib-type="author"><name><surname>Bailly</surname><given-names>Sarah</given-names></name><xref ref-type="aff" rid="AF0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Fritzell</surname><given-names>Camille</given-names></name><xref ref-type="aff" rid="AF0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Berthelot</surname><given-names>L&#x000e9;na</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Vanhomwegen</surname><given-names>Jessica</given-names></name><xref ref-type="aff" rid="AF0003">3</xref></contrib><contrib contrib-type="author"><name><surname>Salje</surname><given-names>Henrik</given-names></name><xref ref-type="aff" rid="AF0004">4</xref></contrib><contrib contrib-type="author"><name><surname>Paireau</surname><given-names>Juliette</given-names></name><xref ref-type="aff" rid="AF0004">4</xref></contrib><contrib contrib-type="author"><name><surname>Matheus</surname><given-names>S&#x000e9;verine</given-names></name><xref ref-type="aff" rid="AF0002">2</xref><xref ref-type="aff" rid="AF0003">3</xref></contrib><contrib contrib-type="author"><name><surname>Enfissi</surname><given-names>Antoine</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Fernandes-Pellerin</surname><given-names>Sandrine</given-names></name><xref ref-type="aff" rid="AF0005">5</xref></contrib><contrib contrib-type="author"><name><surname>Djossou</surname><given-names>F&#x000e9;lix</given-names></name><xref ref-type="aff" rid="AF0006">6</xref></contrib><contrib contrib-type="author"><name><surname>Linares</surname><given-names>S&#x000e9;bastien</given-names></name><xref ref-type="aff" rid="AF0007">7</xref></contrib><contrib contrib-type="author"><name><surname>Carod</surname><given-names>Jean-Fran&#x000e7;ois</given-names></name><xref ref-type="aff" rid="AF0008">8</xref></contrib><contrib contrib-type="author"><name><surname>Kazanji</surname><given-names>Mirdad</given-names></name><xref ref-type="aff" rid="AF0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Manuguerra</surname><given-names>Jean-Claude</given-names></name><xref ref-type="aff" rid="AF0003">3</xref></contrib><contrib contrib-type="author"><name><surname>Cauchemez</surname><given-names>Simon</given-names></name><xref ref-type="aff" rid="AF0004">4</xref></contrib><contrib contrib-type="author"><name><surname>Rousset</surname><given-names>Dominique</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib></contrib-group><aff id="AF0001"><label>1</label>
<institution>Epidemiology Unit</institution>, Cayenne, <country country="GF">French Guiana</country></aff><aff id="AF0002"><label>2</label>
<institution>Arbovirus National Reference Center, Institut Pasteur</institution>, Cayenne, <country country="GF">French Guiana</country></aff><aff id="AF0003"><label>3</label>
<institution>Environment and Infectious Risks Unit, Unit&#x000e9; Mixte de Recherche 2000, Centre National de la Recherche Scientifique</institution>, Paris, <country country="FR">France</country></aff><aff id="AF0004"><label>4</label>
<institution>Mathematical Modelling of Infectious Diseases Unit, Unit&#x000e9; Mixte de Recherche 2000, Centre National de la Recherche Scientifique</institution>, Paris, <country country="FR">France</country></aff><aff id="AF0005"><label>5</label>
<institution>Clinical Coordination of Translational Research Center, Institut Pasteur</institution>, Paris, <country country="FR">France</country></aff><aff id="AF0006"><label>6</label>
<institution>Infectious and Tropical Diseases Unit, Centre Hospitalier Andr&#x000e9;e Rosemon</institution>, Cayenne, <country country="GF">French Guiana</country></aff><aff id="AF0007"><label>7</label>
<institution>Geographic Information and Knowledge Dissemination Unit, Direction de l&#x02019;Environnement, de l&#x02019;Am&#x000e9;nagement et du Logement Guyane</institution>, Cayenne, <country country="GF">French Guiana</country></aff><aff id="AF0008"><label>8</label>
<institution>Medical Laboratory, Centre Hospitalier de l&#x02019;Ouest Guyanais</institution>, Saint-Laurent du Maroni, <country country="GF">French Guiana</country></aff><author-notes><corresp id="c1">Correspondence: C. Flamand, PhD, Unit&#x000e9; d&#x02019;&#x000e9;pid&#x000e9;miologie Institut Pasteur de la Guyane, 23 avenue Louis Pasteur, BP 6010, 97306 Cayenne Cedex, French Guiana (<email>cflamand@pasteur-cayenne.fr</email>).</corresp></author-notes><pub-date pub-type="ppub"><day>15</day><month>12</month><year>2019</year></pub-date><pub-date pub-type="epub" iso-8601-date="2019-08-16"><day>16</day><month>8</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>16</day><month>8</month><year>2019</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>220</volume><issue>12</issue><fpage>1915</fpage><lpage>1925</lpage><history><date date-type="received"><day>02</day><month>5</month><year>2019</year></date><date date-type="accepted"><day>01</day><month>8</month><year>2019</year></date><date date-type="editorial-decision"><day>29</day><month>7</month><year>2019</year></date><date date-type="corrected-typeset"><day>20</day><month>9</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.</copyright-statement><copyright-year>2019</copyright-year><license license-type="cc-by-nc-nd" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p></license></permissions><self-uri xlink:href="jiz396.pdf"/><abstract><title>Abstract</title><sec id="s0100"><title>Background</title><p>Since the identification of Zika virus (ZIKV) in Brazil in May 2015, the virus has spread throughout the Americas. However, ZIKV burden in the general population in affected countries remains unknown.</p></sec><sec id="s0101"><title>Methods</title><p>We conducted a general population survey in the different communities of French Guiana through individual interviews and serologic survey during June&#x02013;October 2017. All serum samples were tested for anti-ZIKV immunoglobulin G antibodies using a recombinant antigen-based SGERPAxMap microsphere immunoassay, and some of them were further evaluated through anti-ZIKV microneutralization tests.</p></sec><sec id="s0102"><title>Results</title><p>The overall seroprevalence was estimated at 23.3% (95% confidence interval [CI], 20.9%&#x02013;25.9%) among 2697 participants, varying from 0% to 45.6% according to municipalities. ZIKV circulated in a large majority of French Guiana but not in the most isolated forest areas. The proportion of reported symptomatic Zika infection was estimated at 25.5% (95% CI, 20.3%&#x02013;31.4%) in individuals who tested positive for ZIKV.</p></sec><sec id="s0103"><title>Conclusions</title><p>This study described a large-scale representative ZIKV seroprevalence study in South America from the recent 2015&#x02013;2016 Zika epidemic. Our findings reveal that the majority of the population remains susceptible to ZIKV, which could potentially allow future reintroductions of the virus.</p></sec></abstract><abstract abstract-type="teaser"><p>This study provides a consistent overview of a large-scale representative Zika virus (ZIKV) seroprevalence study in French Guiana, revealing that the majority of the population remains susceptible to ZIKV, which could potentially allow future reintroductions of the virus.</p></abstract><kwd-group><kwd>Zika virus</kwd><kwd>seroprevalence study</kwd><kwd>general population survey</kwd><kwd>French Guiana</kwd></kwd-group><funding-group><award-group award-type="grant"><funding-source><named-content content-type="funder-name">European Regional Development Fund</named-content><named-content content-type="funder-identifier">10.13039/501100008530</named-content></funding-source><award-id>GY0008695</award-id></award-group><award-group award-type="grant"><funding-source><named-content content-type="funder-name">Regional Health Agency of French Guiana</named-content></funding-source><award-id>CNES-TOSCA-4800000720</award-id></award-group><award-group award-type="grant"><funding-source><named-content content-type="funder-name">National Center of Spatial Studies</named-content></funding-source></award-group><award-group award-type="grant"><funding-source><named-content content-type="funder-name">Pasteur Institut Department of International Affairs</named-content></funding-source></award-group><award-group award-type="grant"><funding-source><named-content content-type="funder-name">AXA Research Fund</named-content><named-content content-type="funder-identifier">10.13039/501100001961</named-content></funding-source></award-group><award-group award-type="grant"><funding-source><named-content content-type="funder-name">Laboratoire d&#x02019;Excellence Integrative Biology of Emerging Infectious Diseases program</named-content></funding-source><award-id>ANR-10-LABX-62-IBEID</award-id></award-group><award-group award-type="grant"><funding-source><named-content content-type="funder-name">Models of Infectious Disease Agent Study</named-content></funding-source><award-id>PIA/ANR-16-CONV-0005</award-id></award-group><award-group award-type="grant"><funding-source><named-content content-type="funder-name">National Institute of General Medical Sciences</named-content><named-content content-type="funder-identifier">10.13039/100000057</named-content></funding-source></award-group><award-group award-type="grant"><funding-source><named-content content-type="funder-name">European Union&#x02019;s Horizon 2020 research</named-content></funding-source><award-id>734548</award-id></award-group></funding-group><counts><page-count count="11"/></counts></article-meta></front><body><p>Zika virus (ZIKV) is a flavivirus transmitted by mosquitoes, primarily <italic>Aedes aegypti</italic>, which also transmits dengue, chikungunya, and yellow fever viruses. It was first isolated in 1947 in African forests, where it circulates between nonhuman primates and sylvatic mosquitoes [<xref rid="CIT0001" ref-type="bibr">1</xref>]. ZIKV was considered as an emergent virus with few sporadic cases reported in Africa and Asia until 2007, when a major epidemic occurred in Yap, Federated States of Micronesia [<xref rid="CIT0002" ref-type="bibr">2</xref>], followed by one in French Polynesia in 2013 [<xref rid="CIT0003" ref-type="bibr">3</xref>, <xref rid="CIT0004" ref-type="bibr">4</xref>]. Subsequently, ZIKV continued to spread in the Pacific region [<xref rid="CIT0005" ref-type="bibr">5</xref>] and emerged in South America in early 2015 [<xref rid="CIT0006" ref-type="bibr">6</xref>, <xref rid="CIT0007" ref-type="bibr">7</xref>]. During these recent outbreaks, the virus was linked to neurological disorders [<xref rid="CIT0008" ref-type="bibr">8</xref>, <xref rid="CIT0009" ref-type="bibr">9</xref>], severe congenital abnormalities, and human birth defects [<xref rid="CIT0010" ref-type="bibr">10&#x02013;14</xref>], leading the World Health Organization to declare a Public Health Emergency of International Concern [<xref rid="CIT0015" ref-type="bibr">15</xref>]. Several recent studies have also highlighted that ZIKV can be transmitted through sexual contact or from mother to fetus [<xref rid="CIT0013" ref-type="bibr">13</xref>, <xref rid="CIT0016" ref-type="bibr">16</xref>, <xref rid="CIT0017" ref-type="bibr">17</xref>]. In French Guiana, a French overseas department of 260 000 inhabitants that is located in Latin America in the Amazonian forest complex, <italic>Ae. aegypti</italic> mosquitoes have been responsible for several major dengue fever outbreaks [<xref rid="CIT0018" ref-type="bibr">18</xref>, <xref rid="CIT0019" ref-type="bibr">19</xref>] and for the chikungunya outbreak in 2014 [<xref rid="CIT0020" ref-type="bibr">20</xref>, <xref rid="CIT0021" ref-type="bibr">21</xref>]. Given the risk of congenital complications, the emergence of ZIKV was particularly concerning for its inhabitants as the territory has the highest fertility rate in the Americas (3.5 children per woman) [<xref rid="CIT0022" ref-type="bibr">22</xref>]. During the ZIKV epidemic in French Guiana (January&#x02013;September 2016), approximately 9700 clinical cases (approximately 4% of the population), with 14 congenital abnormalities including 3 instances of microcephaly, were recorded by local health authorities [<xref rid="CIT0023" ref-type="bibr">23</xref>]. A territory-wide active monitoring of pregnant women implemented during the first 4 months of the outbreak also showed that 573 of 3050 (19%) enrolled pregnant women had laboratory evidence of ZIKV infection [<xref rid="CIT0022" ref-type="bibr">22</xref>]. However, the ZIKV infection burden remains unclear in the general population. In such a context, population-representative seroprevalence studies provide an opportunity to estimate the underlying burden of infection and to assess the potential for future epidemics of ZIKV in the region.</p><p>A number of seroprevalence studies have recently been conducted in affected countries and territories in the Americas among specific subgroups of populations and geographical areas. ZIKV seroprevalence was found to be 63% in patient cohorts and university employees in Salvador, Brazil [<xref rid="CIT0024" ref-type="bibr">24</xref>], 73% in a cohort of individuals residing in Pau da Lima community in the Salvador [<xref rid="CIT0025" ref-type="bibr">25</xref>]. In Bolivia, ZIKV seroprevalence was estimated in blood donors at 39% in Beni, 21.5% in Santa Cruz de la Sierra and close to 0% in three different highland regions (Cochachamba, La Paz and Tarija) [<xref rid="CIT0026" ref-type="bibr">26</xref>]. In Managua, Nicaragua, ZIKV seroprevalence was estimated at 36%, 46%, and 56% among participants of pediatric, household, and adult cohort studies, respectively [<xref rid="CIT0027" ref-type="bibr">27</xref>]. In Suriname, seroprevalence rates were estimated at 35.1% and 24.5% in patient cohorts recruited from urban areas and 1 remote village, respectively [<xref rid="CIT0028" ref-type="bibr">28</xref>]. In the Caribbean sea, ZIKV seroprevalence was estimated at 42.2% in blood donors in Martinique island [<xref rid="CIT0029" ref-type="bibr">29</xref>]. These studies were all performed in a small number of communities or specific population subgroups in a constrained region. It is unclear whether their findings are generalizable to the wider population. No territory-wide study evaluating the impact of ZIKV emergence in the general population has yet been published. Such population-representative studies constitute the most reliable source of information and often estimate seroprevalence rates that are lower but more representative than those obtained in population subgroups [<xref rid="CIT0030" ref-type="bibr">30</xref>, <xref rid="CIT0031" ref-type="bibr">31</xref>].</p><p>In this context, we conducted a cross-sectional study within the general population of French Guiana in the year following the end of the outbreak, to characterize the seroprevalence of ZIKV and assess its association with sociodemographic and geographical factors.</p><sec sec-type="materials" id="s1"><title>METHODS</title><sec id="s2"><title>Study Design and Participants</title><p>We conducted a cross-sectional population-based study through household interviews and serologic survey during June&#x02013;October 2017, involving residents located in the 22 municipalities of French Guiana. The territory is composed of 2 main inhabited geographical regions: a central urbanized and coastal strip area along the Atlantic Ocean (&#x0201c;coastal area&#x0201d;) where a large part of the population lives, and 4 distinct remote areas along the Surinamese and Brazilian frontiers (&#x0201c;interior area&#x0201d;) (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p><fig id="F1" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Map of French Guiana with geographical areas.</p></caption><graphic xlink:href="jiz396f0001"/></fig><p>We estimated the sample size for this survey at 2500 persons distributed in the 5 delimited geographical areas based on a 50% seroprevalence, 95% confidence, 90% power, and a cluster effect. To reach the desired sample size, a total of 1600 households were randomly selected for possible participation in the study from household databases maintained by the Geographic Information and Knowledge Dissemination Unit of the Regional Environment, the planning and housing agency, and the National Institute of Economic and Statistical Information. A stratified simple random sampling method was adopted to select households from the 22 municipalities (strata), allowing an overrepresentation of isolated and small municipalities. Villages from 4 municipalities (Roura, Maripasoula, Regina, and Camopi) were specifically considered in the sample design to ensure that all existing submunicipality areas were adequately represented among the selected households. The distribution of households selected from the 22 strata is presented in <xref rid="T1" ref-type="table">Table 1</xref>. The global sampling fraction of the households was 1:49, varying from 1:103 to 1:5 according to the municipality.</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Description of the Household Selection Process and Weighted Seroprevalence Estimated by Municipality</p></caption><table frame="vsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Municipality and Submunicipality</th><th rowspan="1" colspan="1">Population</th><th rowspan="1" colspan="1">No. of Households</th><th rowspan="1" colspan="1">No. of Selected Households</th><th rowspan="1" colspan="1">No. (%) of Enrolled Households</th><th rowspan="1" colspan="1">No. of Enrolled Individuals</th><th rowspan="1" colspan="1">Weighted Seroprevalence, % (95% CI)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Cayenne</td><td rowspan="1" colspan="1">57 614</td><td rowspan="1" colspan="1">21 659</td><td rowspan="1" colspan="1">210</td><td rowspan="1" colspan="1">196 (0.9)</td><td rowspan="1" colspan="1">446</td><td rowspan="1" colspan="1">25.2 (20.2&#x02013;30.9)</td></tr><tr><td rowspan="1" colspan="1">Matoury</td><td rowspan="1" colspan="1">32 427</td><td rowspan="1" colspan="1">10 778</td><td rowspan="1" colspan="1">180</td><td rowspan="1" colspan="1">136 (1.3)</td><td rowspan="1" colspan="1">265</td><td rowspan="1" colspan="1">22.7 (16.5&#x02013;30.5)</td></tr><tr><td rowspan="1" colspan="1">Saint-Laurent</td><td rowspan="1" colspan="1">43 600</td><td rowspan="1" colspan="1">9770</td><td rowspan="1" colspan="1">180</td><td rowspan="1" colspan="1">170 (1.7)</td><td rowspan="1" colspan="1">301</td><td rowspan="1" colspan="1">32.4 (25.7&#x02013;39.9)</td></tr><tr><td rowspan="1" colspan="1">Kourou</td><td rowspan="1" colspan="1">26 221</td><td rowspan="1" colspan="1">8205</td><td rowspan="1" colspan="1">180</td><td rowspan="1" colspan="1">167 (2.0)</td><td rowspan="1" colspan="1">294</td><td rowspan="1" colspan="1">30.1 (23.8&#x02013;37.3)</td></tr><tr><td rowspan="1" colspan="1">R&#x000e9;mire-Montjoly</td><td rowspan="1" colspan="1">23 976</td><td rowspan="1" colspan="1">8117</td><td rowspan="1" colspan="1">120</td><td rowspan="1" colspan="1">105 (1.3)</td><td rowspan="1" colspan="1">192</td><td rowspan="1" colspan="1">13.7 (8.5&#x02013;20.9)</td></tr><tr><td rowspan="1" colspan="1">Macouria</td><td rowspan="1" colspan="1">11 719</td><td rowspan="1" colspan="1">4218</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">75 (1.8)</td><td rowspan="1" colspan="1">164</td><td rowspan="1" colspan="1">10.9 (6.8&#x02013;17.1)</td></tr><tr><td rowspan="1" colspan="1">Mana</td><td rowspan="1" colspan="1">10 241</td><td rowspan="1" colspan="1">2297</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">74 (3.2)</td><td rowspan="1" colspan="1">96</td><td rowspan="1" colspan="1">16.7 (10.6&#x02013;25.4)</td></tr><tr><td rowspan="1" colspan="1">Maripasoula</td><td rowspan="1" colspan="1">11 856</td><td rowspan="1" colspan="1">1955</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">74 (3.8)</td><td rowspan="1" colspan="1">145</td><td rowspan="1" colspan="1">26.7 (16.6&#x02013;40.0)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Maripasoula center area</td><td rowspan="1" colspan="1">&#x02026;</td><td rowspan="1" colspan="1">&#x02026;</td><td rowspan="1" colspan="1">55</td><td rowspan="1" colspan="1">50</td><td rowspan="1" colspan="1">77</td><td rowspan="1" colspan="1">45.6 (30.0&#x02013;62.0)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Twenke-Talhuen village</td><td rowspan="1" colspan="1">&#x02026;</td><td rowspan="1" colspan="1">&#x02026;</td><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">33</td><td rowspan="1" colspan="1">8.4 (2.6&#x02013;24.0)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Antecume-Pata village</td><td rowspan="1" colspan="1">&#x02026;</td><td rowspan="1" colspan="1">&#x02026;</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">35</td><td rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1">Apatou</td><td rowspan="1" colspan="1">8431</td><td rowspan="1" colspan="1">1839</td><td rowspan="1" colspan="1">50</td><td rowspan="1" colspan="1">45 (2.5)</td><td rowspan="1" colspan="1">62</td><td rowspan="1" colspan="1">19.1 (10.2&#x02013;32.9)</td></tr><tr><td rowspan="1" colspan="1">Grand-Santi</td><td rowspan="1" colspan="1">6969</td><td rowspan="1" colspan="1">1447</td><td rowspan="1" colspan="1">30</td><td rowspan="1" colspan="1">28 (1.9)</td><td rowspan="1" colspan="1">61</td><td rowspan="1" colspan="1">17.1 (8.3&#x02013;32.0)</td></tr><tr><td rowspan="1" colspan="1">Saint-Georges</td><td rowspan="1" colspan="1">4020</td><td rowspan="1" colspan="1">1208</td><td rowspan="1" colspan="1">40</td><td rowspan="1" colspan="1">32 (2.7)</td><td rowspan="1" colspan="1">86</td><td rowspan="1" colspan="1">27.6 (13.6&#x02013;47.9)</td></tr><tr><td rowspan="1" colspan="1">Papa&#x000ef;chton</td><td rowspan="1" colspan="1">7266</td><td rowspan="1" colspan="1">1150</td><td rowspan="1" colspan="1">40</td><td rowspan="1" colspan="1">32 (2.8)</td><td rowspan="1" colspan="1">49</td><td rowspan="1" colspan="1">22.7 (11.1&#x02013;40.8)</td></tr><tr><td rowspan="1" colspan="1">Sinnamary</td><td rowspan="1" colspan="1">2957</td><td rowspan="1" colspan="1">1092</td><td rowspan="1" colspan="1">30</td><td rowspan="1" colspan="1">30 (2.8)</td><td rowspan="1" colspan="1">39</td><td rowspan="1" colspan="1">37.4 (24.0&#x02013;53.1)</td></tr><tr><td rowspan="1" colspan="1">Roura</td><td rowspan="1" colspan="1">3713</td><td rowspan="1" colspan="1">983</td><td rowspan="1" colspan="1">50</td><td rowspan="1" colspan="1">39 (4.0)</td><td rowspan="1" colspan="1">70</td><td rowspan="1" colspan="1">18.7 (9.7&#x02013;32.9)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Roura main area</td><td rowspan="1" colspan="1">&#x02026;</td><td rowspan="1" colspan="1">&#x02026;</td><td rowspan="1" colspan="1">30</td><td rowspan="1" colspan="1">26</td><td rowspan="1" colspan="1">45</td><td rowspan="1" colspan="1">13.7 (5.1&#x02013;31.7)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Cacao village</td><td rowspan="1" colspan="1">&#x02026;</td><td rowspan="1" colspan="1">&#x02026;</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">25</td><td rowspan="1" colspan="1">27.3 (12.2&#x02013;50.4)</td></tr><tr><td rowspan="1" colspan="1">Montsin&#x000e9;ry-Tonn&#x000e9;grande</td><td rowspan="1" colspan="1">2473</td><td rowspan="1" colspan="1">898</td><td rowspan="1" colspan="1">30</td><td rowspan="1" colspan="1">29 (3.2)</td><td rowspan="1" colspan="1">66</td><td rowspan="1" colspan="1">10.7 (2.7&#x02013;33.9)</td></tr><tr><td rowspan="1" colspan="1">Iracoubo</td><td rowspan="1" colspan="1">1878</td><td rowspan="1" colspan="1">585</td><td rowspan="1" colspan="1">30</td><td rowspan="1" colspan="1">29 (5.0)</td><td rowspan="1" colspan="1">53</td><td rowspan="1" colspan="1">10.7 (4.8&#x02013;22.1)</td></tr><tr><td rowspan="1" colspan="1">R&#x000e9;gina</td><td rowspan="1" colspan="1">946</td><td rowspan="1" colspan="1">401</td><td rowspan="1" colspan="1">50</td><td rowspan="1" colspan="1">43 (10.7)</td><td rowspan="1" colspan="1">75</td><td rowspan="1" colspan="1">12.0 (5.8&#x02013;23.4)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;R&#x000e9;gina main area</td><td rowspan="1" colspan="1">&#x02026;</td><td rowspan="1" colspan="1">&#x02026;</td><td rowspan="1" colspan="1">40</td><td rowspan="1" colspan="1">33</td><td rowspan="1" colspan="1">64</td><td rowspan="1" colspan="1">13.1 (5.9&#x02013;26.3)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Kaw village</td><td rowspan="1" colspan="1">&#x02026;</td><td rowspan="1" colspan="1">&#x02026;</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">5.9 (.8&#x02013;34.0)</td></tr><tr><td rowspan="1" colspan="1">Camopi</td><td rowspan="1" colspan="1">1769</td><td rowspan="1" colspan="1">346</td><td rowspan="1" colspan="1">50</td><td rowspan="1" colspan="1">50 (14.5)</td><td rowspan="1" colspan="1">115</td><td rowspan="1" colspan="1">3.7 (1.3&#x02013;9.8)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Camopi main area</td><td rowspan="1" colspan="1">&#x02026;</td><td rowspan="1" colspan="1">&#x02026;</td><td rowspan="1" colspan="1">34</td><td rowspan="1" colspan="1">34</td><td rowspan="1" colspan="1">83</td><td rowspan="1" colspan="1">5.3 (2.0&#x02013;13.5)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Trois-Sauts village</td><td rowspan="1" colspan="1">&#x02026;</td><td rowspan="1" colspan="1">&#x02026;</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">32</td><td rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1">Awala</td><td rowspan="1" colspan="1">1379</td><td rowspan="1" colspan="1">330</td><td rowspan="1" colspan="1">30</td><td rowspan="1" colspan="1">28 (8.5)</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">25.5 (10.2&#x02013;50.7)</td></tr><tr><td rowspan="1" colspan="1">Saint-Elie</td><td rowspan="1" colspan="1">95</td><td rowspan="1" colspan="1">143</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">10 (7.0)</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1">Ouanary</td><td rowspan="1" colspan="1">165</td><td rowspan="1" colspan="1">140</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">5 (3.6)</td><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">11.3 (3.0&#x02013;34.5)</td></tr><tr><td rowspan="1" colspan="1">Sa&#x000fc;l</td><td rowspan="1" colspan="1">150</td><td rowspan="1" colspan="1">94</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">18 (19.2)</td><td rowspan="1" colspan="1">34</td><td rowspan="1" colspan="1">2.1 (.3&#x02013;15.3)</td></tr><tr><td rowspan="1" colspan="1">Total</td><td rowspan="1" colspan="1">259 865</td><td rowspan="1" colspan="1">77 655</td><td rowspan="1" colspan="1">1600</td><td rowspan="1" colspan="1">1415</td><td rowspan="1" colspan="1">2697</td><td rowspan="1" colspan="1">23.3 (20.9&#x02013;25.9)</td></tr></tbody></table><table-wrap-foot><fn id="fn-0100"><p>Abbreviation: CI, confidence interval.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3"><title>Procedures and Ethical Considerations</title><p>Publicity and information about the survey was provided through the media and contact with local and national authorities. Fieldworker teams including investigators and nurses or medicine residents were trained to visit all households, explain the project objectives, and, when allowed, collect participants&#x02019; signatures in a free and informed consent form and carry out the interviews. All members of selected households who were 2&#x02013;75 years of age were invited to take part in the study during a preliminary face-to-face interview. For all participants &#x0003c;18 years of age, 1 or 2 responsible adults signed the informed consent form. A specific educational-style comic book was designed for children 6&#x02013;17 years of age to explain, in an understandable way, the nature and objectives of the survey and inform them about the voluntary nature of their participation in the study and their rights to access and rectify their personal information (<xref ref-type="supplementary-material" rid="sup1">Supplementary Materials 1</xref>).</p><p>Data were collected through a standardized questionnaire installed on tablets to register demographics, socioeconomics, and household characteristics. Participants were asked to report the occurrence of a presumptive ZIKV infection, to report the year of Zika presumptive infection, to list the specific associated symptoms (open-ended question), and to specify if they had consulted a doctor or obtained a biological confirmation of their infection. Thereafter, a venous blood sample of 10 mL was collected from each participant, in accordance with current biosafety standards.</p><p>The study was recorded on ClinicalTrials.gov (NCT03210363) and approved by the Sud-Ouest &#x00026; Outre-Mer IV Ethical Research Committee (number CPP17-007a/2017-A00514-49) and by the French Data Protection Authority (number DR-2017&#x02013;324) responsible for ethical issues and protection of individual data collection.</p></sec><sec id="s4"><title>Laboratory Methods</title><sec id="s5"><title>Blood Sample Collection</title><p>Blood samples were collected into 5-mL gold BD Vacutainer SST II advance tubes with gel for serum separation (Becton-Dickinson). Immediately after puncture, samples were stored at 4&#x000b0;C&#x02013;8&#x000b0;C until centrifugation within 12 hours. Sera were then frozen and stored at &#x02013;20&#x000b0;C until use at the National Reference Center for arboviruses in Institut Pasteur in French Guiana.</p></sec><sec id="s6"><title>Serologic Diagnosis</title><p>All serum samples were tested for anti-ZIKV immunoglobulin G (IgG) antibodies using a recombinant antigen-based SGERPAxMap microsphere immunoassay (MIA) adapted from Beck et al [<xref rid="CIT0032" ref-type="bibr">32</xref>]. ZIKV Luminex MIA uses the ZIKV E3 domain as the epitope rather than the whole E protein as in traditional ELISAs. The E3 domain has been shown to limit cross-reactivity between flaviviruses [<xref rid="CIT0033" ref-type="bibr">33&#x02013;38</xref>] (see <xref ref-type="supplementary-material" rid="sup2">Supplementary Materials and Methods</xref>). In such a way, this assay limits the probability that individuals previously infected with dengue falsely test as ZIKV positive.</p><p>Furthermore, some of the samples were evaluated through anti-ZIKV microneutralization tests (MNTs) adapted from Beck et al [<xref rid="CIT0032" ref-type="bibr">32</xref>]. Away from infection, as is the case in our study, detection of ZIKV neutralizing antibodies provides good evidence of a contact with ZIKV [<xref rid="CIT0039" ref-type="bibr">39</xref>, <xref rid="CIT0040" ref-type="bibr">40</xref>] (<xref ref-type="supplementary-material" rid="sup2">Supplementary Materials and Methods</xref>).</p><p>ZIKV MNT was systematically performed on the first 235 samples to evaluate the correlation between ZIKV MIA and MNT results and to confirm MIA cutoffs.</p><p>ZIKV neutralizing antibodies from the MNT were detected in 63 of 65 (96.9%) of samples with an MIA ratio of &#x0003e;2.5, in 26 of 36 (72.2%) of samples with an MIA ratio between 1.5 and 2.5, and in 12 of 134 (9%) of samples with an MIA ratio of &#x0003c;1.5. A sample was considered positive if its MIA ratio was &#x0003e;2.5 and negative for a value &#x0003c;1.5. All samples with an MIA ratio between 1.5 and 2.5 were tested by MNT and considered positive for neutralizing titers &#x0003e;20. MNT was also systematically performed where the MIA ratio was &#x0003c;1.5 for anyone who had reported an arboviral-like infection in the last 2 years (<xref ref-type="supplementary-material" rid="sup1">Supplementary Materials 2</xref>). Finally, almost a quarter of the samples (22.5%; n = 607) were also tested by anti-ZIKV MNTs.</p></sec></sec><sec id="s7"><title>Statistical Analysis</title><p>We use the following notation to describe the study design (<xref rid="T1" ref-type="table">Table 1</xref>):</p><list list-type="bullet"><list-item><p>
<italic>i</italic>: one of the 22 strata (municipalities)</p></list-item><list-item><p>
<italic>M</italic>
<sub><italic>i</italic></sub>: number of primary sampling units (households) in the <italic>i</italic><sup>th</sup> stratum, <italic>i =</italic> 1, &#x02026;, 22</p></list-item><list-item><p>
<italic>S</italic>
<sub><italic>i</italic></sub>: number of primary sampling units (households) selected from the <italic>i</italic><sup>th</sup> stratum, <italic>i =</italic> 1, &#x02026;, 22</p></list-item><list-item><p>
<italic>mi</italic>: number of primary sampling units (households) actually enrolled from the <italic>i</italic><sup>th</sup> stratum, i = 1, &#x02026;, 22</p></list-item><list-item><p>
<italic>P</italic>
<sub><italic>i</italic></sub>: number of individuals living within the <italic>i</italic><sup>th</sup> stratum, <italic>i =</italic> 1, &#x02026;, 22 (census data)</p></list-item><list-item><p>
<italic>p</italic>
<sub><italic>i</italic></sub>: number of individuals actually enrolled in the <italic>i</italic><sup>th</sup> stratum, <italic>i =</italic> 1, &#x02026;, 22</p></list-item></list><p>We considered, that, in each municipality <italic>i</italic>, the probability of selecting a particular subject was equal to the probability to select his or her household and was (<italic>m</italic><sub><italic>i</italic></sub><italic>/M</italic><sub><italic>i</italic></sub>), corresponding to a statistical weight equal to (1/ <italic>m</italic><sub><italic>i</italic></sub><italic>/M</italic><sub><italic>i</italic></sub>)<sub><italic> =</italic></sub>(<italic>M</italic><sub><italic>i</italic></sub><italic>/m</italic><sub><italic>i</italic></sub>). This statistical weight indicates the number of people in the population represented by each subject in the sample.</p><p>We applied a poststratification adjustment to each of these weights to arrive at the final statistical weight for each subject. This adjustment allowed us to weight the age-sex groups within each municipality to match the distribution in the French Guiana total population. Ten age groups (2&#x02013;4, 5&#x02013;9, 10&#x02013;14, 15&#x02013;19, 20&#x02013;24, 25&#x02013;34, 35&#x02013;44, 45&#x02013;54, 55&#x02013;64 &#x02265;65 years) were used within male and female groups, and for each age-sex subgroup, we applied an adjustment factor <italic>c</italic><sub><italic>ijk</italic>,</sub> to have a final statistical weight <italic>w</italic><sub><italic>ijk</italic></sub><italic> =</italic> (<italic>M</italic><sub><italic>i</italic></sub><italic>/m</italic><sub><italic>i</italic></sub>) &#x000d7; <italic>c</italic><sub><italic>ijk</italic></sub>, where <italic>i</italic> indexes municipalities, <italic>j</italic> indexes sex groups, and <italic>k</italic> indexes age groups.</p><p>We constructed a household socioeconomic index combining a multiple correspondence analysis and a hierarchical cluster analysis (<xref ref-type="supplementary-material" rid="sup2">Supplementary Materials and Methods</xref>). Type of housing, housing equipment such as access to drinking water and electricity, presence of a garden, private swimming pool, refrigerator, air conditioning, internet access, mobile phone, car, boat, type of health insurance, household income, and highest educational level were included to determine and characterize the natural groupings of households regarding socioeconomic levels.</p><p>The outcome of interest was the weighted ZIKV seroprevalence estimate, and the associated factors were identified by using a survey-weighted Poisson regression and prevalence ratios (PRs). Any variable having a significant univariate test with a <italic>P</italic> value cutoff point of 0.25 was selected as a candidate for the multivariate analysis. The strength of the association between selected variables and ZIKV seropositivity was estimated by crude and adjusted PRs with their 95% confidence interval (CI), all PRs excluding 1.0 being considered as significant.</p><p>Analyses were carried out using survey capabilities of Stata version 15 statistical software [<xref rid="CIT0041" ref-type="bibr">41</xref>] and SPAD 8 [<xref rid="CIT0042" ref-type="bibr">42</xref>]. Spatial analyses were performed using QGIS software [<xref rid="CIT0043" ref-type="bibr">43</xref>].</p></sec></sec><sec id="s8"><title>RESULTS</title><p>In total, 1415 households and 2697 individuals were included from the 27 recruitment areas (<xref rid="T1" ref-type="table">Table 1</xref>). The mean household size was 1.9 individuals (range, 1&#x02013;11). The mean age was 34.1 years (range, 2&#x02013;75 years). Comparison of the sociodemographic characteristics of the study sample to the census data demonstrated an overrepresentation of women (58.9% vs 50% in the general population of French Guiana) and adults &#x0003e;25 years of age (64% vs 53% in French Guiana). These differences were accounted for in the analyses of seroprevalence and risk factors by allocating poststratification weight to each participant.</p><p>The crude proportion seropositive was 21.6% and the overall weighted seroprevalence of ZIKV antibodies in French Guiana was 23.3% (95% CI, 20.9%&#x02013;25.9%) (<xref rid="T1" ref-type="table">Table 1</xref>). The seroprevalence did not differ according to sex (<italic>P</italic> = .65) or age (<italic>P</italic> = .47) (<xref rid="T2" ref-type="table">Table 2</xref>). Serological results in the different geographical areas are shown in <xref ref-type="fig" rid="F2">Figure 2</xref>. While ZIKV circulated in a large part of French Guiana, it barely reached the interior and remote villages located in the most isolated forest areas (Saint-Elie, Sa&#x000fc;l, Talhuen-Twenke villages, and Camopi) (<xref rid="T1" ref-type="table">Table 1</xref>). Elevated probabilities of infection were observed in the main population centers in Maroni river (Maripasoula main area: 45.6% [95% CI, 30.0%&#x02013;62.0%]; Saint-Laurent: 32.4% [95% CI, 25.7%&#x02013;39.9%]), in the coastal area (Kourou: 30.1% [95% CI, 23.8%&#x02013;37.3%]; Cayenne: 25.2% [95% CI, 20.2%&#x02013;30.9%]), and in Low-Oyapock (Saint-Georges: 27.6% [95% CI, 13.6%&#x02013;47.9%]). Two smaller geographical areas in the coastal area were also strongly impacted (Sinnamary: 37.4% [95% CI, 24.0%&#x02013;53.1%]; Cacao: 27.3% [95% CI, 12.2%&#x02013;50.4%]). Living in the northwestern part of the territory, so-called &#x0201c;Low Maroni,&#x0201d; in urban areas and being born in Haiti was significantly associated with being seropositive in both univariate and multivariate analyses (<xref rid="T2" ref-type="table">Table 2</xref>). Living in a carbet, representing a typical Native American cabin without walls essentially located in the Amazonian forest complex in High Oyapock, interior, and high Maroni villages, was significantly associated with being ZIKV seronegative at univariate level. The seroprevalence estimated in makeshift houses was higher than in individual or collective type of housing. However, this difference was not significant, probably due to small numbers of individuals in this category. Benefiting from universal health coverage or state medical assistance and having a low household income was associated with being seropositive at the univariate level. However, socioeconomic factors and type of housing were no longer significant after adjusting by geographical regions.</p><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Factors Associated With Zika Virus Seropositivity</p></caption><table frame="vsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Characteristic</th><th rowspan="1" colspan="1">Total No. of Tested Individuals</th><th rowspan="1" colspan="1">Weighted Prevalence, % <break/>(95% CI)</th><th rowspan="1" colspan="1">Crude PR (95% CI)</th><th rowspan="1" colspan="1">Pearson <italic>P</italic> Value</th><th rowspan="1" colspan="1">Adjusted PR <break/>(95% CI)</th></tr></thead><tbody><tr><td colspan="5" rowspan="1">Sex</td><td rowspan="1" colspan="1">&#x02026;</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Male</td><td rowspan="1" colspan="1">1108</td><td rowspan="1" colspan="1">22.8 (19.6&#x02013;26.5)</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1">.65</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Female</td><td rowspan="1" colspan="1">1589</td><td rowspan="1" colspan="1">23.8 (21.0&#x02013;26.8)</td><td rowspan="1" colspan="1">1.04 (.87&#x02013;1.24)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td colspan="5" rowspan="1">Age, y</td><td rowspan="1" colspan="1">&#x02026;</td></tr><tr><td rowspan="1" colspan="1">&#x02003;2&#x02013;4</td><td rowspan="1" colspan="1">63</td><td rowspan="1" colspan="1">27.0 (15.2&#x02013;43.3)</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1">.47</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;5&#x02013;14</td><td rowspan="1" colspan="1">494</td><td rowspan="1" colspan="1">24.1 (19.1&#x02013;30.1)</td><td rowspan="1" colspan="1">.89 (.50&#x02013;1.59)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;15&#x02013;24</td><td rowspan="1" colspan="1">413</td><td rowspan="1" colspan="1">25.9 (21.0&#x02013;31.6)</td><td rowspan="1" colspan="1">.96 (.56&#x02013;1.66)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;25&#x02013;34</td><td rowspan="1" colspan="1">471</td><td rowspan="1" colspan="1">23.6 (19.2&#x02013;28.7)</td><td rowspan="1" colspan="1">.87 (.51&#x02013;1.50)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;35&#x02013;44</td><td rowspan="1" colspan="1">442</td><td rowspan="1" colspan="1">19.7 (15.8&#x02013;24.3)</td><td rowspan="1" colspan="1">.73 (.43&#x02013;1.25)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;45&#x02013;54</td><td rowspan="1" colspan="1">362</td><td rowspan="1" colspan="1">21.2 (16.5&#x02013;26.8)</td><td rowspan="1" colspan="1">.78 (.44&#x02013;1.39)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;55&#x02013;64</td><td rowspan="1" colspan="1">284</td><td rowspan="1" colspan="1">18.9 (14.3&#x02013;24.6)</td><td rowspan="1" colspan="1">.70 (.39&#x02013;1.27)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02265;65</td><td rowspan="1" colspan="1">168</td><td rowspan="1" colspan="1">28.3 (20.4&#x02013;37.7)</td><td rowspan="1" colspan="1">1.05 (.56&#x02013;1.95)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td colspan="6" rowspan="1">Region of residence</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Coastal area</td><td rowspan="1" colspan="1">1820</td><td rowspan="1" colspan="1">22.2 (19.4&#x02013;25.3)</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1">.06</td><td rowspan="1" colspan="1">Ref</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Low Maroni</td><td rowspan="1" colspan="1">424</td><td rowspan="1" colspan="1">28.8 (23.4&#x02013;34.8)</td><td rowspan="1" colspan="1">1.29 (1.02&#x02013;1.64)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.41 (1.02&#x02013;1.95)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;High Maroni</td><td rowspan="1" colspan="1">194</td><td rowspan="1" colspan="1">25.5 (17.2&#x02013;36.0)</td><td rowspan="1" colspan="1">1.15 (.78&#x02013;1.70)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.51 (.91&#x02013;2.50)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Low Oyapock</td><td rowspan="1" colspan="1">99</td><td rowspan="1" colspan="1">27.0 (13.5&#x02013;46.8)</td><td rowspan="1" colspan="1">1.21 (.64&#x02013;2.32)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.77 (.89&#x02013;3.52)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;High Oyapock</td><td rowspan="1" colspan="1">115</td><td rowspan="1" colspan="1">3.7 (1.3&#x02013;9.8)</td><td rowspan="1" colspan="1">.16 (.61&#x02013;.46)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">.26 (.94&#x02013;.75)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Interior</td><td rowspan="1" colspan="1">45</td><td rowspan="1" colspan="1">1.0 (.1&#x02013;6.9)</td><td rowspan="1" colspan="1">.04 (.01&#x02013;.33)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">.07 (.01&#x02013;.52)</td></tr><tr><td colspan="5" rowspan="1">Type of housing</td><td rowspan="1" colspan="1">&#x02026;</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Building/collective</td><td rowspan="1" colspan="1">365</td><td rowspan="1" colspan="1">21.5 (16.4&#x02013;27.6)</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1">.05</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Individual</td><td rowspan="1" colspan="1">1768</td><td rowspan="1" colspan="1">23.8 (20.8&#x02013;27.2)</td><td rowspan="1" colspan="1">1.11 (.83&#x02013;1.49)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Carbet</td><td rowspan="1" colspan="1">213</td><td rowspan="1" colspan="1">5.9 (1.6&#x02013;18.9)</td><td rowspan="1" colspan="1">.27 (.08&#x02013;.97)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Makeshift</td><td rowspan="1" colspan="1">89</td><td rowspan="1" colspan="1">28.3 (17.7&#x02013;42.1)</td><td rowspan="1" colspan="1">1.32 (.79&#x02013;2.19)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td colspan="6" rowspan="1">Type of zone</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Rural</td><td rowspan="1" colspan="1">1304</td><td rowspan="1" colspan="1">19.4 (16.2&#x02013;23.1)</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1">.03</td><td rowspan="1" colspan="1">Ref</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Urban</td><td rowspan="1" colspan="1">1393</td><td rowspan="1" colspan="1">24.8 (21.7&#x02013;28.1)</td><td rowspan="1" colspan="1">1.28 (1.02&#x02013;1.58)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.45 (1.11&#x02013;1.91)</td></tr><tr><td colspan="6" rowspan="1">Birth place</td></tr><tr><td rowspan="1" colspan="1">&#x02003;French Guiana</td><td rowspan="1" colspan="1">1481</td><td rowspan="1" colspan="1">23.4 (20.2&#x02013;27.1)</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1">&#x0003c;10<sup>&#x02013;2</sup></td><td rowspan="1" colspan="1">Ref</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Suriname</td><td rowspan="1" colspan="1">213</td><td rowspan="1" colspan="1">27.0 (20.2&#x02013;35.1)</td><td rowspan="1" colspan="1">1.15 (.85&#x02013;1.57)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.08 (.75&#x02013;1.56)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Brazil</td><td rowspan="1" colspan="1">174</td><td rowspan="1" colspan="1">19.1 (13.3&#x02013;26.7)</td><td rowspan="1" colspan="1">.82 (.56&#x02013;1.19)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">.82 (.55&#x02013;1.22)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Other South America</td><td rowspan="1" colspan="1">63</td><td rowspan="1" colspan="1">27.6 (17.7&#x02013;40.3)</td><td rowspan="1" colspan="1">1.18 (.77&#x02013;1.80)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.18 (.74&#x02013;1.88)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Haiti</td><td rowspan="1" colspan="1">223</td><td rowspan="1" colspan="1">34.3 (20.6&#x02013;42.3)</td><td rowspan="1" colspan="1">1.46 (1.14&#x02013;1.88)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.45 (1.08&#x02013;1.94)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Caribbean island</td><td rowspan="1" colspan="1">136</td><td rowspan="1" colspan="1">20.6 (13.5&#x02013;30.2)</td><td rowspan="1" colspan="1">.88 (.58&#x02013;1.34)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">.82 (.51&#x02013;1.31)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Europe</td><td rowspan="1" colspan="1">349</td><td rowspan="1" colspan="1">17.0 (12.4&#x02013;22.8)</td><td rowspan="1" colspan="1">.72 (.52&#x02013;1.01)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">.76 (.54&#x02013;1.08)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Asia</td><td rowspan="1" colspan="1">28</td><td rowspan="1" colspan="1">4.6 (1.08&#x02013;17.6)</td><td rowspan="1" colspan="1">.20 (.04&#x02013;.82)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">.23 (.05&#x02013;1.14)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Africa</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">12.4 (3.1&#x02013;38.6)</td><td rowspan="1" colspan="1">.53 (.14&#x02013;1.97)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">.56 (.15&#x02013;2.15)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Others</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">6.1 (.7&#x02013;36.6)</td><td rowspan="1" colspan="1">.26 (.03&#x02013;2.04)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">.32 (.04&#x02013;2.50)</td></tr><tr><td colspan="5" rowspan="1">Household size</td><td rowspan="1" colspan="1">&#x02026;</td></tr><tr><td rowspan="1" colspan="1">&#x02003;1&#x02013;2</td><td rowspan="1" colspan="1">536</td><td rowspan="1" colspan="1">20.0 (16.2&#x02013;24.5)</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1">.41</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;3&#x02013;5</td><td rowspan="1" colspan="1">1359</td><td rowspan="1" colspan="1">24.1 (20.7&#x02013;27.8)</td><td rowspan="1" colspan="1">1.20 (.93&#x02013;1.55)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02265;6</td><td rowspan="1" colspan="1">592</td><td rowspan="1" colspan="1">24.6 (18.8&#x02013;31.6)</td><td rowspan="1" colspan="1">1.23 (.88&#x02013;1.72)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td colspan="6" rowspan="1">Household income, &#x020ac;</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x0003c;1000</td><td rowspan="1" colspan="1">565</td><td rowspan="1" colspan="1">26.9 (22.2&#x02013;32.1)</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1">.10</td><td rowspan="1" colspan="1">Ref</td></tr><tr><td rowspan="1" colspan="1">&#x02003;1000&#x02013;2999</td><td rowspan="1" colspan="1">833</td><td rowspan="1" colspan="1">24.5 (19.7&#x02013;29.9)</td><td rowspan="1" colspan="1">.83 (.48&#x02013;1.41)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">.92 (.67&#x02013;1.25)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;3000&#x02013;4999</td><td rowspan="1" colspan="1">285</td><td rowspan="1" colspan="1">17.7 (12.5&#x02013;24.3)</td><td rowspan="1" colspan="1">.53 (.33&#x02013;.86)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">.72 (.46&#x02013;1.12)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02265;5000</td><td rowspan="1" colspan="1">153</td><td rowspan="1" colspan="1">15.7 (9.4&#x02013;24.9)</td><td rowspan="1" colspan="1">.48 (.24&#x02013;.94)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">.66 (.37&#x02013;1.16)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Not documented</td><td rowspan="1" colspan="1">861</td><td rowspan="1" colspan="1">24.0 (19.8&#x02013;28.8)</td><td rowspan="1" colspan="1">.78 (.56&#x02013;1.10)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">.87 (.62&#x02013;1.22)</td></tr><tr><td colspan="6" rowspan="1">Socioeconomic index</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Low</td><td rowspan="1" colspan="1">233</td><td rowspan="1" colspan="1">16.3 (10.8&#x02013;23.9)</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1">.06</td><td rowspan="1" colspan="1">Ref</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Intermediate</td><td rowspan="1" colspan="1">908</td><td rowspan="1" colspan="1">26.5 (21.8&#x02013;31.8)</td><td rowspan="1" colspan="1">1.63 (1.04&#x02013;2.53)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.48 (.96&#x02013;2.26)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Elevated</td><td rowspan="1" colspan="1">1291</td><td rowspan="1" colspan="1">21.4 (18.3&#x02013;24.9)</td><td rowspan="1" colspan="1">1.31 (.85&#x02013;2.02)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.59 (.97&#x02013;2.59)</td></tr><tr><td colspan="5" rowspan="1">Health insurance status</td><td rowspan="1" colspan="1">&#x02026;</td></tr><tr><td rowspan="1" colspan="1">&#x02003;General social coverage</td><td rowspan="1" colspan="1">1330</td><td rowspan="1" colspan="1">20.2 (17.3&#x02013;23.5)</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1">&#x0003c;10<sup>&#x02013;2</sup></td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;Universal health coverage</td><td rowspan="1" colspan="1">1233</td><td rowspan="1" colspan="1">25.4 (21.5&#x02013;29.7)</td><td rowspan="1" colspan="1">1.26 (1.00&#x02013;1.57)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;State medical assistance</td><td rowspan="1" colspan="1">128</td><td rowspan="1" colspan="1">36.9 (27.6&#x02013;47.2)</td><td rowspan="1" colspan="1">1.83 (1.34&#x02013;2.49)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;No healthcare</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">20.1 (2.5&#x02013;70.8)</td><td rowspan="1" colspan="1">.99 (.16&#x02013;6.94)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="fn-0101"><p>Abbreviations: CI, confidence interval; PR, prevalence ratio.</p></fn></table-wrap-foot></table-wrap><fig id="F2" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Spatial distribution of Zika virus seroprevalence, French Guiana.</p></caption><graphic xlink:href="jiz396f0002"/></fig><p>The proportion of reported symptoms was estimated at 25.5% (95% CI, 20.3%&#x02013;31.4%) in ZIKV-positive participants vs 3.6% (95% CI, 2.6%&#x02013;5.0%) in seronegative individuals, resulting in a ZIKV-attributable symptomatic infection rate of 21.9%.</p><p>This proportion varied substantially over space from 27.3% in the coastal area to only 12.8% in the High Maroni area, but did not vary significantly by sex (28.6% in ZIKV-positive women vs 21.8% in ZIKV-positive men; <italic>P</italic> = .22). More than 95% of infected individuals who reported the occurrence of a presumptive ZIKV infection reported a year of occurrence between 2015 and 2017, corresponding to the period of transmission of ZIKV in French Guiana. Three-quarters of them (75.8%) declared that diagnosis was confirmed by a clinician and 54.7% declared that they had a laboratory confirmation. Fever (80.5%) and myalgia (62.4%) were the most frequently reported symptoms in ZIKV-positive participants. However, only rash (38.0%) and arthralgia (33.9%) were significantly more prevalent in ZIKV-positive individuals (<xref rid="T3" ref-type="table">Table 3</xref>).</p><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3.</label><caption><p>Clinical Symptoms Reported, by Zika Virus Infection Status</p></caption><table frame="vsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Clinical Symptoms</th><th colspan="2" rowspan="1">Total (N = 147)</th><th colspan="2" rowspan="1">ZIKV-Positive Individuals (n = 96)</th><th colspan="2" rowspan="1">ZIKV-Negative Individuals (n = 51)</th><th rowspan="2" colspan="1">Pearson <italic>P</italic> Value</th></tr><tr><th rowspan="1" colspan="1">No.</th><th rowspan="1" colspan="1">(%)</th><th rowspan="1" colspan="1">No.</th><th rowspan="1" colspan="1">(%)</th><th rowspan="1" colspan="1">No.</th><th rowspan="1" colspan="1">(%)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Fever</td><td rowspan="1" colspan="1">118</td><td rowspan="1" colspan="1">(81.4)</td><td rowspan="1" colspan="1">77</td><td rowspan="1" colspan="1">(80.5)</td><td rowspan="1" colspan="1">41</td><td rowspan="1" colspan="1">(83.0)</td><td rowspan="1" colspan="1">.98</td></tr><tr><td rowspan="1" colspan="1">Arthralgia</td><td rowspan="1" colspan="1">84</td><td rowspan="1" colspan="1">(52.2)</td><td rowspan="1" colspan="1">62</td><td rowspan="1" colspan="1">(33.9)</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">(61.9)</td><td rowspan="1" colspan="1">.01</td></tr><tr><td rowspan="1" colspan="1">Myalgia</td><td rowspan="1" colspan="1">93</td><td rowspan="1" colspan="1">(63.1)</td><td rowspan="1" colspan="1">61</td><td rowspan="1" colspan="1">(62.4)</td><td rowspan="1" colspan="1">32</td><td rowspan="1" colspan="1">(64.2)</td><td rowspan="1" colspan="1">.92</td></tr><tr><td rowspan="1" colspan="1">Rash</td><td rowspan="1" colspan="1">52</td><td rowspan="1" colspan="1">(30.1)</td><td rowspan="1" colspan="1">41</td><td rowspan="1" colspan="1">(38.0)</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">(15.3)</td><td rowspan="1" colspan="1">.01</td></tr><tr><td rowspan="1" colspan="1">Conjunctival hyperemia</td><td rowspan="1" colspan="1">28</td><td rowspan="1" colspan="1">(18.0)</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">(21.9)</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">(10.6)</td><td rowspan="1" colspan="1">.10</td></tr></tbody></table><table-wrap-foot><fn id="fn-0102"><p>Abbreviation: ZIKV, Zika virus.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s9"><title>DISCUSSION</title><p>Here we have presented a large-scale representative ZIKV seroprevalence study in South America from the recent 2015&#x02013;2016 Zika epidemic. We found that approximately a quarter of the population of French Guiana became infected during the outbreak. However, there was substantial heterogeneity in infection risk, with communities in the center of the territory hardly affected at all, whereas up to half of the population was infected in urban communities along the coast. Our results were consistent with a recent report from a systematic monitoring of pregnant women in French Guiana that estimated at 19% the proportion of ZIKV-positive women during the first 4 months of the outbreak [<xref rid="CIT0025" ref-type="bibr">25</xref>].</p><p>Our seroprevalence estimates are slightly lower than most previous estimates from seroprevalence studies in other locations in South America [<xref rid="CIT0024" ref-type="bibr">24&#x02013;28</xref>] and in other parts of the world [<xref rid="CIT0002" ref-type="bibr">2</xref>, <xref rid="CIT0034" ref-type="bibr">34</xref>].This highlights the importance of conducting population-representative studies. The previous studies in South America have all consisted of single communities or small numbers of neighboring populations. Therefore, it has not been possible to generalize the findings to the wider country as is the case here, where the entire territory was included in the initial sampling frame. The future risk of ZIKV in the area remains unclear. It has been shown in a study conducted in Thailand that ZIKV can transition to stable endemic circulation [<xref rid="CIT0044" ref-type="bibr">44</xref>]. Our findings demonstrate that the majority of the population remains susceptible to ZIKV, which would potentially allow future successful reintroductions of the virus. However, the observed differences in seropositivity across the country may partly reflect differences in the distribution of mosquitoes across the territory. Population movements, economic development, and urbanization have facilitated the geographical expansion of <italic>Ae. aegypti</italic> and its implantation in almost all inhabited areas of French Guiana, even in villages along the Maroni river up to the Maripasoula main area and inland up to Sa&#x000fc;l [<xref rid="CIT0045" ref-type="bibr">45</xref>, <xref rid="CIT0046" ref-type="bibr">46</xref>]. However, to date no study has reported the presence of <italic>Ae. aegypti</italic> populations in the most remote villages including Antecume Pata, Twenke-Talhuen, and Camopi [<xref rid="CIT0046" ref-type="bibr">46</xref>], where seroprevalence rates varied from 0% to 8%. Furthermore, despite strengthening existing epidemiological surveillance systems [<xref rid="CIT0047" ref-type="bibr">47</xref>] and entomo-epidemiological investigations coordinated by local health authorities when a clinical or confirmed case appeared in these areas, no autochthonous transmission of <italic>Aedes</italic>-transmitted diseases has been identified in these villages.</p><p>Differences in vector control activities implemented in the different geographical areas may also have contributed to variability in transmission intensities between municipalities. Indeed, the French Guiana program of surveillance and management of arboviral diseases includes <italic>Ae</italic>. <italic>aegypti</italic> density reduction throughout the year, which is intensified during outbreaks. Vector control activities include both indoor and outdoor spatial spraying of deltamethrin against adults and the removal of breeding sites or their treatment with <italic>Bacillus thuringiensis</italic> var. <italic>israelensis</italic>&#x02013;based larvicides [<xref rid="CIT0048" ref-type="bibr">48</xref>]. These activities rely on important logistical and human resources that can be in some situations very difficult to apply uniformly in the different geographical areas of French Guiana.</p><p>We found that individuals with higher income and benefiting from general health insurance had a reduced risk of infection compared to those with lower income and benefiting from universal health or state medical assistance in the univariate risk factor analysis. However, after correcting for spatial differences in risk, no individual or household-level factor was associated with being seropositive. This suggests that the individual risk of infection is more deeply modulated by different ecoenvironments related to geographic factors, urbanization level, and the related quality of sanitary infrastructures that may have an impact on the extent of vector infestation and, hence, viral circulation.</p><p>Whereas the proportion of asymptomatic ZIKV infection in ZIKV-positive participants was estimated in previous general population cross-sectional studies at 43% in French Polynesia [<xref rid="CIT0034" ref-type="bibr">34</xref>], 47% in Puerto Rico [<xref rid="CIT0049" ref-type="bibr">49</xref>], and 62% in Yap, Micronesia [<xref rid="CIT0002" ref-type="bibr">2</xref>], we found that 74.5% (95% CI, 68.5%&#x02013;79.8%) of the participants with ZIKV IgG did not report symptoms confirming the high proportion of asymptomatic ZIKV infection. Considering that the survey was conducted 8 months after the end of the ZIKV epidemic in French Guiana, recall bias may nonetheless have led to underreporting of symptoms, particularly when there was a considerable time delay between the symptoms&#x02019; occurrence and the time of the survey. Furthermore, even if numerous education campaigns may have considerably increased public awareness of health risks related to arboviruses in a large majority of the population, awareness about Zika; cultural, social, and behavioral practices; or previous expositions to diseases and parasites may have affected the reporting of presumptive ZIKV infection.</p><p>Our study has other limitations inherent to the study design and cross-reaction issues in the context of co-circulation of related arboviruses.</p><p>First, given that individuals without health coverage could not be enrolled in our survey because of restrictions from French legislation, immigrants without health coverage were underrepresented in our sample. Although this population was very small in the majority of the municipalities, some households were excluded in the western border part of the territory, which is known for high levels of immigration, because the adults and household referents did not have health insurance status. Second, sample size calculation was determined to obtain a sufficient point estimate of prevalence but not to study risk factors of infection so that we might lack power to ascertain them. Finally, cross-reaction between viruses of the same family could have affected the interpretation of seroprevalence results. In particular, dengue has circulated in French Guiana for decades. Here we used an assay that minimizes the risk of cross-reaction by relying on the E3 domain of the ZIKV in combination with virus neutralization assay (MNT).We estimated that 9% of those with lower MIA values were still seropositive. This means that the true proportion seropositive may be slightly higher than our estimates; however, as 76.4% of samples had low MIA results, this would only raise the proportion seropositive from 23.3% to 27.1%.</p><p>In conclusion, this study is the first to provide a consistent overview of a territory-wide ZIKV seropositivity estimation in the Americas. Given that a huge proportion of ZIKV infections are clinically asymptomatic and that the disease is greatly underreported, our results provide distinctive and useful information per geographical area and population subgroups in a continental area frequently exposed to arbovirus.</p></sec><sec sec-type="supplementary-material" id="s10"><title>Supplementary Data</title><p>Supplementary materials are available at <italic>The Journal of Infectious Diseases</italic> online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author.</p><supplementary-material content-type="local-data" id="sup1"><label>jiz396_suppl_Supplementary_Data</label><media xlink:href="jiz396_suppl_supplementary_data.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="sup2"><label>jiz396_suppl_Supplementary_Material</label><media xlink:href="jiz396_suppl_supplementary_material.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="sup3"><label>jiz396_suppl_Supplementary_Table_S1</label><media xlink:href="jiz396_suppl_supplementary_table_s1.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><notes id="n1"><title>Notes</title><p>Presented in part: 2019 Annual Conference of the International Society for Disease Surveillance, San Diego, California, 29 January&#x02013;1 February 2019; and Neglected Tropical Diseases Congress: Future Challenges, Dubai, United Arab Emirates, 5&#x02013;6 December 2018.</p><p>
<bold><italic>Acknowledgments.</italic></bold> We thank Laurine Levillayer from the Institut Pasteur of Paris, Dr Paul Brousse from the Cayenne Hospital Center, Dr Katia Le Goaziou from the National Institute of Economic and Statistical Information, and all collaborators and field workers involved in the Arbovirus Epidemiologic Survey (EPI-ARBO) project. We also thank Laetitia Bremand, Bhety Labeau, David Moua, and Marine Rangon from the Arbovirus National Reference Center for their valuable contributions to the laboratory analyses.</p><p>
<bold><italic>Disclaimer.</italic></bold> The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p><p>
<bold><italic>Financial support.</italic></bold> This study was supported by the European Regional Development Fund under EPI-ARBO grant agreement GY0008695; the Regional Health Agency of French Guiana; and the National Center of Spatial Studies. C. Fl. acknowledges financial support from the Centre National d&#x02019;Etudes Spatiales-Terre solide, Oc&#x000e9;an, Surfaces Continentales, Atmosph&#x000e8;re fund (grant number CNES-TOSCA-4800000720) and funding from Calmette and Yersin allocated by the Pasteur Institut Department of International Affairs. S. C. acknowledges financial support from the AXA Research Fund, the Investissement d&#x02019;Avenir program, the Laboratoire d&#x02019;Excellence Integrative Biology of Emerging Infectious Diseases program (grant number ANR-10-LABX-62-IBEID), the Models of Infectious Disease Agent Study of the National Institute of General Medical Sciences, the INCEPTION project (PIA/ANR-16-CONV-0005), and the European Union&#x02019;s Horizon 2020 research and innovation program under ZIKAlliance grant agreement number 734548.</p><p>
<bold><italic>Potential conflicts of interest.</italic></bold> All authors: No reported conflicts of interest.</p><p>All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.</p></notes><ref-list id="r1"><title>REFERENCES</title><ref id="CIT0001"><label>1.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Dick</surname><given-names>GW</given-names></name>, <name name-style="western"><surname>Kitchen</surname><given-names>SF</given-names></name>, <name name-style="western"><surname>Haddow</surname><given-names>AJ</given-names></name></person-group>
<article-title>Zika virus. I. Isolations and serological specificity</article-title>. <source>Trans R Soc Trop Med Hyg</source><year>1952</year>; <volume>46</volume>:<fpage>509</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">12995440</pub-id></mixed-citation></ref><ref id="CIT0002"><label>2.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Duffy</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>Hancock</surname><given-names>WT</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Zika virus outbreak on Yap Island, Federated States of Micronesia</article-title>. <source>N Engl J Med</source><year>2009</year>; <volume>360</volume>:<fpage>2536</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="pmid">19516034</pub-id></mixed-citation></ref><ref id="CIT0003"><label>3.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ioos</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mallet</surname><given-names>HP</given-names></name>, <name name-style="western"><surname>Leparc Goffart</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Gauthier</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Cardoso</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Herida</surname><given-names>M</given-names></name></person-group>
<article-title>Current Zika virus epidemiology and recent epidemics</article-title>. <source>Med Mal Infect</source><year>2014</year>; <volume>44</volume>:<fpage>302</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">25001879</pub-id></mixed-citation></ref><ref id="CIT0004"><label>4.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Jouannic</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Friszer</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Leparc-Goffart</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Garel</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Eyrolle-Guignot</surname><given-names>D</given-names></name></person-group>
<article-title>Zika virus infection in French Polynesia</article-title>. <source>Lancet</source><year>2016</year>; <volume>387</volume>:<fpage>1051</fpage>&#x02013;<lpage>2</lpage>.</mixed-citation></ref><ref id="CIT0005"><label>5.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Musso</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Nilles</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Cao-Lormeau</surname><given-names>VM</given-names></name></person-group>
<article-title>Rapid spread of emerging Zika virus in the Pacific area</article-title>. <source>Clin Microbiol Infect</source><year>2014</year>; <volume>20</volume>:<fpage>O595</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">24909208</pub-id></mixed-citation></ref><ref id="CIT0006"><label>6.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Musso</surname><given-names>D</given-names></name></person-group>
<article-title>Zika virus transmission from French Polynesia to Brazil</article-title>. <source>Emerg Infect Dis</source><year>2015</year>; <volume>21</volume>:<fpage>1887</fpage>.</mixed-citation></ref><ref id="CIT0007"><label>7.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Pettersson</surname><given-names>JH-O</given-names></name>, <name name-style="western"><surname>Eldholm</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Seligman</surname><given-names>SJ</given-names></name>, <etal>et al</etal></person-group>
<article-title>How did Zika virus emerge in the Pacific Islands and Latin America?</article-title>
<source>mBio</source>. <year>2016</year>; <volume>7</volume>.</mixed-citation></ref><ref id="CIT0008"><label>8.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Brasil</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Sequeira</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Freitas</surname><given-names>AD</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Guillain-Barr&#x000e9; syndrome associated with Zika virus infection</article-title>. <source>Lancet</source><year>2016</year>; <volume>387</volume>:<fpage>1482</fpage>.<pub-id pub-id-type="pmid">27115821</pub-id></mixed-citation></ref><ref id="CIT0009"><label>9.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Cao-Lormeau</surname><given-names>VM</given-names></name>, <name name-style="western"><surname>Blake</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mons</surname><given-names>S</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Guillain-Barr&#x000e9; syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study</article-title>. <source>Lancet</source><year>2016</year>; <volume>387</volume>:<fpage>1531</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">26948433</pub-id></mixed-citation></ref><ref id="CIT0010"><label>10.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Driggers</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>CY</given-names></name>, <name name-style="western"><surname>Korhonen</surname><given-names>EM</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Zika virus infection with prolonged maternal viremia and fetal brain abnormalities</article-title>. <source>N Engl J Med</source><year>2016</year>; <volume>374</volume>:<fpage>2142</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="pmid">27028667</pub-id></mixed-citation></ref><ref id="CIT0011"><label>11.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rasmussen</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Jamieson</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Honein</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Petersen</surname><given-names>LR</given-names></name></person-group>
<article-title>Zika virus and birth defects&#x02014;reviewing the evidence for causality</article-title>. <source>N Engl J Med</source><year>2016</year>; <volume>374</volume>:<fpage>1981</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">27074377</pub-id></mixed-citation></ref><ref id="CIT0012"><label>12.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Cauchemez</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Besnard</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bompard</surname><given-names>P</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study</article-title>. <source>Lancet</source><year>2016</year>; <volume>387</volume>:<fpage>2125</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">26993883</pub-id></mixed-citation></ref><ref id="CIT0013"><label>13.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Calvet</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Aguiar</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Melo</surname><given-names>ASO</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study</article-title>. <source>Lancet Infect Dis</source><year>2016</year>; <volume>16</volume>:<fpage>653</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">26897108</pub-id></mixed-citation></ref><ref id="CIT0014"><label>14.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hoen</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Schaub</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Funk</surname><given-names>AL</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Pregnancy outcomes after ZIKV infection in French territories in the Americas</article-title>. <source>N Engl J Med</source><year>2018</year>; <volume>378</volume>:<fpage>985</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="pmid">29539287</pub-id></mixed-citation></ref><ref id="CIT0015"><label>15.</label><mixed-citation publication-type="book">
<collab>World Health Organization.</collab>
<source>Statement on the first meeting of the International Health Regulations (2005) (IHR 2005). Emergency Committee on Zika virus and observed increase in neurological disorders and neonatal malformations</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>WHO</publisher-name>, <year>2016</year>.</mixed-citation></ref><ref id="CIT0016"><label>16.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hills</surname><given-names>SL</given-names></name></person-group>
<article-title>Transmission of Zika virus through sexual contact with travelers to areas of ongoing transmission&#x02014;continental United States, 2016</article-title>. <source>MMWR Morb Mortal Wkly Rep</source><year>2016</year>; <volume>65</volume>:<fpage>215</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">26937739</pub-id></mixed-citation></ref><ref id="CIT0017"><label>17.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>D&#x02019;Ortenzio</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Matheron</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yazdanpanah</surname><given-names>Y</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Evidence of sexual transmission of Zika virus</article-title>. <source>N Engl J Med</source><year>2016</year>; <volume>374</volume>:<fpage>2195</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">27074370</pub-id></mixed-citation></ref><ref id="CIT0018"><label>18.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>L&#x02019;Azou</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Taurel</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Flamand</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Qu&#x000e9;nel</surname><given-names>P</given-names></name></person-group>
<article-title>Recent epidemiological trends of dengue in the French territories of the Americas (2000&#x02013;2012): a systematic literature review</article-title>. <source>PLoS Negl Trop Dis</source><year>2014</year>; <volume>8</volume>:<fpage>e3235</fpage>.<pub-id pub-id-type="pmid">25375627</pub-id></mixed-citation></ref><ref id="CIT0019"><label>19.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Flamand</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Fritzell</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Prince</surname><given-names>C</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Epidemiological assessment of the severity of dengue epidemics in French Guiana</article-title>. <source>PLoS One</source><year>2017</year>; <volume>12</volume>:<fpage>e0172267</fpage>.<pub-id pub-id-type="pmid">28196111</pub-id></mixed-citation></ref><ref id="CIT0020"><label>20.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fritzell</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Raude</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Adde</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dusfour</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Quenel</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Flamand</surname><given-names>C</given-names></name></person-group>
<article-title>Knowledge, attitude and practices of vector-borne disease prevention during the emergence of a new arbovirus: implications for the control of chikungunya virus in French Guiana</article-title>. <source>PLoS Negl Trop Dis</source><year>2016</year>; <volume>10</volume>:<fpage>e0005081</fpage>.<pub-id pub-id-type="pmid">27802275</pub-id></mixed-citation></ref><ref id="CIT0021"><label>21.</label><mixed-citation publication-type="journal">Flamand C, Fritzell C, Obale P, Quenel P, Raude J. <article-title>The role of risk proximity in the beliefs and behaviors related to mosquito-borne diseases: the case of chikungunya in French Guiana</article-title>. <source>Am J Trop Med Hyg</source><year>2017</year>; <volume>97</volume>:<fpage>344</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="pmid">28722640</pub-id></mixed-citation></ref><ref id="CIT0022"><label>22.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Flamand</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Fritzell</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Matheus</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>The proportion of asymptomatic infections and spectrum of disease among pregnant women infected by Zika virus: systematic monitoring in French Guiana, 2016</article-title>. <source>Euro Surveill Bull</source><year>2017</year>; <volume>22</volume>. doi:<pub-id pub-id-type="doi">10.2807/1560-7917.ES.2017.22.44.17-00102</pub-id>.</mixed-citation></ref><ref id="CIT0023"><label>23.</label><mixed-citation publication-type="webpage">
<collab>Sant&#x000e9; Publique France</collab>. <comment>Situation &#x000e9;pid&#x000e9;miologique du virus Zika aux Antilles Guyane.</comment><year>2016</year>
<uri xlink:type="simple" xlink:href="http://www.santepubliquefrance.fr/regions/guyane/documents/bulletin-regional/2016/situation-epidemiologique-du-virus-zika-aux-antilles-guyane.-point-au-10-novembre-2016">http://www.santepubliquefrance.fr/regions/guyane/documents/bulletin-regional/2016/situation-epidemiologique-du-virus-zika-aux-antilles-guyane.-point-au-10-novembre-2016</uri> Accessed <comment>16 August 2019</comment>.</mixed-citation></ref><ref id="CIT0024"><label>24.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Netto</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Moreira-Soto</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pedroso</surname><given-names>C</given-names></name>, <etal>et al</etal></person-group>
<article-title>High Zika virus seroprevalence in Salvador, northeastern Brazil limits the potential for further outbreaks</article-title>. <source>mBio</source><year>2017</year>; <volume>8</volume>. doi:<pub-id pub-id-type="doi">10.1128/mBio.01390-17</pub-id>.</mixed-citation></ref><ref id="CIT0025"><label>25.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rodriguez-Barraquer</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Nascimento</surname><given-names>EJM</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region</article-title>. <source>Science</source><year>2019</year>; <volume>363</volume>:<fpage>607</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">30733412</pub-id></mixed-citation></ref><ref id="CIT0026"><label>26.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Saba Villarroel</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Nurtop</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Pastorino</surname><given-names>B</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Zika virus epidemiology in Bolivia: a seroprevalence study in volunteer blood donors</article-title>. <source>PLoS Negl Trop Dis</source><year>2018</year>; <volume>12</volume>:<fpage>e0006239</fpage>.<pub-id pub-id-type="pmid">29513667</pub-id></mixed-citation></ref><ref id="CIT0027"><label>27.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Zambrana</surname><given-names>JV</given-names></name>, <name name-style="western"><surname>Bustos Carrillo</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Burger-Calderon</surname><given-names>R</given-names></name>, <etal>et al</etal></person-group>
<article-title>Seroprevalence, risk factor, and spatial analyses of Zika virus infection after the 2016 epidemic in Managua, Nicaragua</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2018</year>; <volume>115</volume>:<fpage>9294</fpage>&#x02013;<lpage>99</lpage>.<pub-id pub-id-type="pmid">30150394</pub-id></mixed-citation></ref><ref id="CIT0028"><label>28.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Langerak</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Brinkman</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Mumtaz</surname><given-names>N</given-names></name>, <etal>et al</etal></person-group>
<article-title>Zika virus seroprevalence in urban and rural areas of Suriname, 2017</article-title>. <source>J Infect Dis</source><year>2019</year>; <volume>220</volume>:<fpage>28</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">30753538</pub-id></mixed-citation></ref><ref id="CIT0029"><label>29.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gallian</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Cabi&#x000e9;</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Richard</surname><given-names>P</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Zika virus in asymptomatic blood donors in Martinique</article-title>. <source>Blood</source><year>2017</year>; <volume>129</volume>:<fpage>263</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">27827826</pub-id></mixed-citation></ref><ref id="CIT0030"><label>30.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fritzell</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rousset</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Adde</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kazanji</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Van Kerkhove</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Flamand</surname><given-names>C</given-names></name></person-group>
<article-title>Current challenges and implications for dengue, chikungunya and Zika seroprevalence studies worldwide: a scoping review</article-title>. <source>PLoS Negl Trop Dis</source><year>2018</year>; <volume>12</volume>:<fpage>e0006533</fpage>.<pub-id pub-id-type="pmid">30011271</pub-id></mixed-citation></ref><ref id="CIT0031"><label>31.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Salje</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Paul</surname><given-names>KK</given-names></name>, <name name-style="western"><surname>Paul</surname><given-names>R</given-names></name>, <etal>et al</etal></person-group>
<article-title>Nationally-representative serostudy of dengue in Bangladesh allows generalizable disease burden estimates</article-title>. <source>eLife</source><year>2019</year>; <volume>8</volume>:<fpage>e42869</fpage>.<pub-id pub-id-type="pmid">30958263</pub-id></mixed-citation></ref><ref id="CIT0032"><label>32.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Beck</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Despr&#x000e8;s</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Paulous</surname><given-names>S</given-names></name>, <etal>et al.</etal></person-group>
<article-title>A high-performance multiplex immunoassay for serodiagnosis of flavivirus-associated neurological diseases in horses</article-title>. <source>Biomed Res Int</source><year>2015</year>; <volume>2015</volume>:<fpage>678084</fpage>.<pub-id pub-id-type="pmid">26457301</pub-id></mixed-citation></ref><ref id="CIT0033"><label>33.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Aubry</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Finke</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Teissier</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>Seroprevalence of arboviruses among blood donors in French Polynesia, 2011&#x02013;2013</article-title>. <source>Int J Infect Dis</source><year>2015</year>; <volume>41</volume>:<fpage>11</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">26482390</pub-id></mixed-citation></ref><ref id="CIT0034"><label>34.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Aubry</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Teissier</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Huart</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>Zika virus seroprevalence, French Polynesia, 2014&#x02013;2015</article-title>. <source>Emerg Infect Dis</source><year>2017</year>; <volume>23</volume>:<fpage>669</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="pmid">28084987</pub-id></mixed-citation></ref><ref id="CIT0035"><label>35.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Aubry</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Teissier</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Huart</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>Seroprevalence of dengue and chikungunya virus antibodies, French Polynesia, 2014&#x02013;2015</article-title>. <source>Emerg Infect Dis</source><year>2018</year>; <volume>24</volume>:<fpage>558</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="pmid">29460745</pub-id></mixed-citation></ref><ref id="CIT0036"><label>36.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kama</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Aubry</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Naivalu</surname><given-names>T</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Sustained low-level transmission of Zika and chikungunya viruses after emergence in the Fiji Islands</article-title>. <source>Emerg Infect Dis</source><year>2019</year>; <volume>25</volume>:<fpage>1535</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">31310218</pub-id></mixed-citation></ref><ref id="CIT0037"><label>37.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kucharski</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Kama</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Watson</surname><given-names>CH</given-names></name>, <etal>et al</etal></person-group>
<article-title>Using paired serology and surveillance data to quantify dengue transmission and control during a large outbreak in Fiji</article-title>. <source>eLife</source><year>2018</year>; <volume>7</volume>.</mixed-citation></ref><ref id="CIT0038"><label>38.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Simon</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Acket</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Forfait</surname><given-names>C</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Zika virus outbreak in New Caledonia and Guillain-Barr&#x000e9; syndrome: a case-control study</article-title>. <source>J Neurovirol</source><year>2018</year>; <volume>24</volume>:<fpage>362</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">29594985</pub-id></mixed-citation></ref><ref id="CIT0039"><label>39.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Swanstrom</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Plante</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Plante</surname><given-names>KS</given-names></name>, <etal>et al</etal></person-group>
<article-title>Dengue virus envelope dimer epitope monoclonal antibodies isolated from dengue patients are protective against Zika virus</article-title>. <source>mBio</source>. <year>2016</year>; <volume>7</volume>. doi:<pub-id pub-id-type="doi">10.1128/mBio.01123-16</pub-id>.</mixed-citation></ref><ref id="CIT0040"><label>40.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Collins</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>McGowan</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Jadi</surname><given-names>R</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Lack of durable cross-neutralizing antibodies against Zika virus from dengue virus infection</article-title>. <source>Emerg Infect Dis</source><year>2017</year>; <volume>23</volume>:<fpage>773</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="pmid">28418292</pub-id></mixed-citation></ref><ref id="CIT0041"><label>41.</label><mixed-citation publication-type="book">
<collab>StataCorp</collab>. <source>Stata statistical software: release 15</source>. <publisher-loc>College Station, TX</publisher-loc>: <publisher-name>StataCorp LLC</publisher-name>, <year>2017</year>.</mixed-citation></ref><ref id="CIT0042"><label>42.</label><mixed-citation publication-type="book">
<source>SPAD Data Mining, v. 8.0 Software Program</source>. <publisher-loc>Suresnes, France</publisher-loc>: <publisher-name>Coheris Corp</publisher-name>, <year>2013</year>.</mixed-citation></ref><ref id="CIT0043"><label>43.</label><mixed-citation publication-type="book">
<collab>QGIS Development Team</collab>. <source>QGIS Geographic Information System</source>. <publisher-loc>Beaverton, OR</publisher-loc>: <publisher-name>Open</publisher-name><publisher-name>Source Geospatial Foundation</publisher-name>, <year>2009</year>.</mixed-citation></ref><ref id="CIT0044"><label>44.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ruchusatsawat</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wongjaroen</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Posanacharoen</surname><given-names>A</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Long-term circulation of Zika virus in Thailand: an observational study</article-title>. <source>Lancet Infect Dis</source><year>2019</year>; <volume>19</volume>:<fpage>439</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="pmid">30826189</pub-id></mixed-citation></ref><ref id="CIT0045"><label>45.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fouque</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Carinci</surname><given-names>R</given-names></name></person-group>
<article-title><italic>Aedes aegypti</italic> in French Guiana. Some aspects of history, general ecology and vertical transmission of the dengue virus [in French]</article-title>. <source>Bull Soc Pathol Exot</source><year>1996</year>; <volume>89</volume>:<fpage>115</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">8924768</pub-id></mixed-citation></ref><ref id="CIT0046"><label>46.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Epelboin</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Chaney</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Guidez</surname><given-names>A</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Successes and failures of sixty years of vector control in French Guiana: what is the next step?</article-title>
<source>Mem Inst Oswaldo Cruz</source>
<year>2018</year>; <volume>113</volume>:<fpage>e170398</fpage>.<pub-id pub-id-type="pmid">29538490</pub-id></mixed-citation></ref><ref id="CIT0047"><label>47.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Flamand</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Quenel</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ardillon</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Carvalho</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Bringay</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Teisseire</surname><given-names>M</given-names></name></person-group>
<article-title>The epidemiologic surveillance of dengue-fever in French Guiana: when achievements trigger higher goals</article-title>. <source>Stud Health Technol Inform</source><year>2011</year>; <volume>169</volume>:<fpage>629</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="pmid">21893824</pub-id></mixed-citation></ref><ref id="CIT0048"><label>48.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Dusfour</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Zorrilla</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Guidez</surname><given-names>A</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Deltamethrin resistance mechanisms in <italic>Aedes aegypti</italic> populations from three French overseas territories worldwide</article-title>. <source>PLoS Negl Trop Dis</source><year>2015</year>; <volume>9</volume>:<fpage>e0004226</fpage>.<pub-id pub-id-type="pmid">26588076</pub-id></mixed-citation></ref><ref id="CIT0049"><label>49.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lozier</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Burke</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Lopez</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group>
<article-title>Differences in prevalence of symptomatic zika virus infection, by age and sex&#x02014;Puerto Rico, 2016</article-title>. <source>J Infect Dis</source><year>2018</year>; <volume>217</volume>:<fpage>1678</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">29216376</pub-id></mixed-citation></ref></ref-list></back></article>